Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?

被引：3
作者：
Jones, Kimberley [1 ]
Gandhi, Maher K. [1 ,2 ]
机构：
[1] Queensland Inst Med Res, Clin Immunohaematol Lab, Brisbane, Qld 4006, Australia
[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld 4102, Australia
来源：
LEUKEMIA & LYMPHOMA | 2009年 / 50卷 / 05期
关键词：
HODGKINS-LYMPHOMA; CELL LYMPHOMA; EBV DNA; BLOOD; SERUM;
D O I：
10.1080/10428190902847716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：684 / 686
页数：3
相关论文
共 16 条
[1]   Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients [J].
Anker, P ;
Mulcahy, H ;
Chen, XQ ;
Stroun, M .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :65-73
[2]   Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients [J].
Au, WY ;
Pang, A ;
Choy, C ;
Chim, CS ;
Kwong, YL .
BLOOD, 2004, 104 (01) :243-249
[3]   Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study [J].
Dupuis, Jehan ;
Emile, Jean-Francois ;
Mounier, Nicolas ;
Gisselbrecht, Christian ;
Martin-Garcia, Nadine ;
Petrella, Tony ;
Bouabdallah, Reda ;
Berger, Francoise ;
Delmer, Alain ;
Coiffier, Bertrand ;
Reyes, Felix ;
Gaulard, Philippe .
BLOOD, 2006, 108 (13) :4163-4169
[4]  
Gallagher A, 1999, INT J CANCER, V84, P442, DOI 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.3.CO
[5]  
2-A
[6]  
Gandhi Maher K, 2006, Expert Rev Anti Infect Ther, V4, P77, DOI 10.1586/14787210.4.1.77
[7]   Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma [J].
Gandhi, MK ;
Lambley, E ;
Burrows, J ;
Dua, U ;
Elliott, S ;
Shaw, PJ ;
Prince, HM ;
Wolf, M ;
Clarke, K ;
Underhill, C ;
Mills, T ;
Mollee, P ;
Gill, D ;
Marlton, P ;
Seymour, JF ;
Khanna, R .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :460-464
[8]   High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens [J].
Han, H. S. ;
Escalon, M. P. ;
Hsiao, B. ;
Serafini, A. ;
Lossos, I. S. .
ANNALS OF ONCOLOGY, 2009, 20 (02) :309-318
[9]   Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study [J].
Keegan, THM ;
Glaser, SL ;
Clarke, CA ;
Gulley, ML ;
Craig, FE ;
DiGiuseppe, JA ;
Dorfman, RF ;
Mann, RB ;
Ambinder, RF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7604-7613
[10]  
KIM WS, LEUK LYMPHO IN PRESS
12